Market Snapshot

BSE Sensex: 73832.55 -0.20%
BSE 500: 34580.95 -0.53%
BSE 200: 10778.02 -0.51%
BSE 100: 24571.58 -0.41%
BSE BANKEX: 62158.35 0.16%
BSE IT: 27061.3 -1.78%
Nifty 50: 23161.6 0.00%
Nifty 500: 22114.45 0.00%
Nifty 200: 13333.7 0.00%
Nifty 100: 24104.7 0.00%
Nifty Midcap 100: 59325.4 0.00%
Nifty Small 100: 17702.6 0.00%
Nifty IT: 27821 0.00%
Nifty PSU Bank: 8303.95 0.00%

News:

BHEL bags over Rs 90-cr LNTP f...
Fractal Analytics ends higher ...
Mahindra EPC Irrigation bags R...
DOMS Inds surges after inking ...
MTAR Technologies Ltd leads lo...

Aspira Pathlab & Diagnostics Ltd Share Price – BSE
Healthcare, Small Cap

Invest

11 Jun 2026 | 03:59 PM

118.20

0.00 (0.00%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

95.6%

Return (1Y)

Beaten BSE Sensex by 103.14%
More Volatile

3.87%

Standard Deviation (1Y)

Higher than BSE Sensex by 3.03%
Consistent Performer

7/12

Months

beaten BSE Sensex
AxisDirect View

No View

52 Week High-Low

136

49

News & Announcements

Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.69 crore in the March 2026 quarter

19 days ago

Aspira Pathlab & Diagnostics to announce Quarterly Result
25 days ago

Aspira Pathlab & Diagnostics to announce Quarterly Result

19 - May - 2026 12:00 | 25 days ago

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 23 May 2026.
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 1.56 crore in the December 2025 quarter
122 days ago

Aspira Pathlab & Diagnostics reports standalone net loss of Rs 1.56 crore in the December 2025 quarter

11 - Feb - 2026 12:00 | 122 days ago

Net loss of Aspira Pathlab & Diagnostics reported to Rs 1.56 crore in the quarter ended December 2025 as against net profit of Rs 0.38 crore during the previous quarter ended December 2024. Sales declined 5.36% to Rs 5.12 crore in the quarter ended December 2025 as against Rs 5.41 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 5.12 5.41 -5

OPM % -23.63 14.23 -

PBDT -1.18 0.77 PL

PBT -1.56 0.38 PL

NP -1.56 0.38 PL

Powered by Capital Market - Live News
Aspira Pathlab & Diagnostics to declare Quarterly Results
128 days ago

Aspira Pathlab & Diagnostics to declare Quarterly Results

05 - Feb - 2026 12:00 | 128 days ago

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 10 February 2026.
Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

Aspira Pathlab & Diagnostics Ltd has the Lowesr P/E ratio according to FY 202603 data among stocks in Healthcare Sector
Aspira Pathlab & Diagnostics Ltd has the Lowesr P/B ratio according to FY 202603 data among stocks in Healthcare Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60